19 Pulmonary Embolism Clinical Trials in Kansas City, MO (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Pulmonary Embolism Studies in Kansas City

NCT05110989Recruiting

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operati...

Kansas City, MO5,000 participantsAtriCure, Inc.

View Study Details

NCT06888011Recruiting

iAmHealthy Clinical Practice Guideline (CPG)

The current study is a multilevel factorial design RCT with interventions at the clinic (Healthy Clinic intervention period vs. Control period) and individual patient levels (iAmHealthy vs. Newsletter...

Kansas City, MONA1,024 participantsUniversity of Kansas Medical Center

View Study Details

NCT05301140Recruiting

Vivistim Registry for Paired VNS Therapy (GRASP)

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment...

Kansas City, MO1,000 participantsMicroTransponder Inc.

View Study Details

NCT04553523Recruiting

Hydrus® Microstent New Enrollment Post-Approval Study

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will und...

Kansas City, MONA545 participantsAlcon Research

View Study Details

NCT07365332Recruiting

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

This is an adaptive, 2-part, randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of IKT-001 in adult participants with WHO Grou...

Kansas City, MOPHASE3486 participantsInhibikase Therapeutics

View Study Details

NCT06274801Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study...

Kansas City, MOPHASE3330 participantsGB002, Inc.

View Study Details

NCT04808596Recruiting

Pulmonary Hypertension Biorepository and Registry

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease....

Kansas City, MO300 participantsUniversity of Kansas Medical Center

View Study Details

NCT06880770Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

This study will evaluate the efficacy and safety of plozasiran in approximately 140 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP)...

Kansas City, MOPHASE3288 participantsArrowhead Pharmaceuticals

View Study Details

NCT06649110Recruiting

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)...

Kansas City, MOPHASE1232 participantsNovartis Pharmaceuticals

View Study Details

NCT07527650Recruiting

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks....

Kansas City, MOPHASE2180 participantsHanmi Pharmaceutical Company Limited

View Study Details

NCT05799599Recruiting

Peer Interventions for Preschoolers With Autism

This proposal will evaluate a series of peer-mediated interventions (PMIs) for preschool children (3 to 6 years) with ASD and limited or no spoken language, using an innovative Sequential Multiple Ass...

Kansas City, MONA132 participantsUniversity of Kansas

View Study Details

NCT06630000Recruiting

Focused Acceptance and Commitment Therapy (FACT)

This is a randomized clinical trial of Focused Acceptance and Commitment Therapy (FACT) vs. an attention-control condition (placebo) for improving the mental health of parents of children with pediatr...

Kansas City, MONA80 participantsChildren's Mercy Hospital Kansas City

View Study Details

NCT07600177Recruiting

Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

This is an investigator-initiated two-center study. The goal of this study is to investigate the feasibility, safety and efficacy outcomes of a seamless transition from mavacamten to aficamten in pati...

Kansas City, MOPHASE440 participantsOregon Health and Science University

View Study Details

NCT07175038Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH). Each eligible parti...

Kansas City, MOPHASE240 participantsAllRock Bio, Inc.

View Study Details

NCT02484248Recruiting

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

Acid reduction remains the most common treatment prescribed empirically by pediatric gastroenterologists for children with functional dyspepsia (FD). When acid reduction therapy fails to provide patie...

Kansas City, MOPHASE340 participantsCraig A. Friesen, MD

View Study Details

NCT05766839Recruiting

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia...

Kansas City, MOPHASE232 participantsVifor Pharma, Inc.

View Study Details

NCT07458568Recruiting

ViBandz Feasibility Study

This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic....

Kansas City, MO30 participantsChildren's Mercy Hospital Kansas City

View Study Details

NCT03794466Recruiting

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a posi...

Kansas City, MO30 participantsUniversity of Kansas Medical Center

View Study Details

NCT07333183Recruiting

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung ...

Kansas City, MOPHASE220 participantsPulmovant, Inc.

View Study Details

About Pulmonary Embolism Clinical Trials in Kansas City

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 19 pulmonary embolism clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 9,829 participants. Research is being sponsored by AtriCure, Inc., University of Kansas Medical Center, MicroTransponder Inc. and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Kansas City — FAQ

Are there pulmonary embolism clinical trials in Kansas City?

Yes, there are 19 pulmonary embolism clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 19 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated September 4, 2026 from ClinicalTrials.gov